Daiwa SB Investments Ltd. boosted its stake in UnitedHealth Group Inc. (NYSE:UNH) by 0.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,100 shares of the healthcare conglomerate’s stock after buying an additional 100 shares during the period. UnitedHealth Group accounts for about 1.6% of Daiwa SB Investments Ltd.’s investment portfolio, making the stock its 29th largest position. Daiwa SB Investments Ltd.’s holdings in UnitedHealth Group were worth $6,174,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Perkins Coie Trust Co boosted its stake in shares of UnitedHealth Group by 1.7% in the second quarter. Perkins Coie Trust Co now owns 18,516 shares of the healthcare conglomerate’s stock valued at $2,614,000 after buying an additional 312 shares during the period. Chevy Chase Trust Holdings Inc. boosted its stake in shares of UnitedHealth Group by 2.7% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 1,095,944 shares of the healthcare conglomerate’s stock valued at $154,747,000 after buying an additional 28,945 shares during the period. Exxonmobil Investment Management Inc. TX boosted its stake in shares of UnitedHealth Group by 6.3% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 246,116 shares of the healthcare conglomerate’s stock valued at $34,752,000 after buying an additional 14,650 shares during the period. DNB Asset Management AS boosted its stake in shares of UnitedHealth Group by 5.1% in the second quarter. DNB Asset Management AS now owns 573,902 shares of the healthcare conglomerate’s stock valued at $81,035,000 after buying an additional 27,800 shares during the period. Finally, Washington Trust Bank boosted its stake in shares of UnitedHealth Group by 0.4% in the second quarter. Washington Trust Bank now owns 29,319 shares of the healthcare conglomerate’s stock valued at $4,140,000 after buying an additional 109 shares during the period. Institutional investors own 84.92% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc. (NYSE:UNH) traded down 0.46% during midday trading on Monday, reaching $152.11. The company’s stock had a trading volume of 5,023,544 shares. UnitedHealth Group Inc. has a 52 week low of $107.51 and a 52 week high of $154.50. The company’s 50-day moving average is $143.37 and its 200 day moving average is $139.61. The firm has a market capitalization of $144.61 billion, a P/E ratio of 25.31 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping the consensus estimate of $2.08 by $0.09. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The business earned $46.30 billion during the quarter, compared to the consensus estimate of $46.09 billion. During the same quarter in the prior year, the firm earned $1.77 earnings per share. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. Analysts expect that UnitedHealth Group Inc. will post $8.01 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 13th. Stockholders of record on Friday, December 2nd will be paid a dividend of $0.625 per share. The ex-dividend date of this dividend is Wednesday, November 30th. This represents a $2.50 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio (DPR) is 36.93%.

WARNING: This piece of content was originally published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2016/11/28/daiwa-sb-investments-ltd-raises-stake-in-unitedhealth-group-inc-unh.html.

Several analysts have issued reports on UNH shares. Jefferies Group reaffirmed a “buy” rating and set a $163.00 target price on shares of UnitedHealth Group in a research report on Sunday, October 16th. Vetr raised UnitedHealth Group from a “buy” rating to a “buy” rating in a research report on Friday, October 7th. Evercore ISI assumed coverage on UnitedHealth Group in a research report on Thursday, September 22nd. They set a “buy” rating and a $155.00 target price on the stock. Cowen and Company set a $150.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research report on Tuesday, September 6th. Finally, Leerink Swann set a $175.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research report on Wednesday, October 19th. Two analysts have rated the stock with a hold rating and twenty-two have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $158.03.

In related news, Director Kenneth Irwin Shine sold 325 shares of the firm’s stock in a transaction dated Friday, October 21st. The shares were sold at an average price of $144.99, for a total value of $47,121.75. Following the completion of the sale, the director now owns 28,613 shares in the company, valued at $4,148,598.87. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the sale, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The disclosure for this sale can be found here. Insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.